The changes of MDA, SOD and T-AOC were more significant in group X than in group L (P<0.05), also suggesting that Xuezhikang is more effective than lovastatin in alleviating oxidative stress in rats with hyperlipidemia and atherosclerosis (Table 2). This evidence concerns the gene SOD1 and hyperlipidemia.